METHODS FOR IMPROVING ISLET SIGNALING IN DIABETES MELLITUS AND FOR ITS PREVENTION

Details for Australian Patent Application No. 2002331226 (hide)

Owner PROBIODRUG AG

Inventors DEMUTH, Hans-Ulrich; GLUND, Konrad; POSPISILIK, Andrew, J.; KUHNWACHE, Kerstin

Pub. Number AU-A-2002331226

PCT Number PCT/EP02/08931

PCT Pub. Number WO2004/017989

Filing date 9 August 2002

Wipo publication date 11 March 2004

International Classifications

A61K 038/55 Medicinal preparations containing peptides - Protease inhibitors

A61K 031/00

A61P 003/06 Drugs for disorders of the metabolism

A61P 003/10 Drugs for disorders of the metabolism

Event Publications

6 February 2003 Complete Application Filed

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2002331226

28 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331227-2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity

2002331225-USE OF INHIBITORS OF PROLINE ENDOPEPTIDASE TO MODULATE INOSITOL (1,4,5) TRIPHOSPHATE CONCENTRATION DEPENDENT ON INTRACELLULAR SIGNAL CASCADES